A promising ALS drug may help combat glioblastoma by targeting the cancerous stem cells that fuel tumor growth.

Glioblastomas are aggressive brain tumors with a median survival time of less than 22 months despite standard therapy ...

Glioblastomas are aggressive brain tumors with a median survival time of less than 22 months despite standard therapy including surgery, irradiation, and chemotherapy.

At-home brain stimulation therapy can safely and effectively treat severe to moderate depression, a new clinical trial shows.

In a startling turn of events at a Kentucky hospital, a man declared brain-dead after a drug overdose regained consciousness ...

Glioblastomas are aggressive brain tumors with a median survival time of less than 22 months despite standard therapy including surgery, irradiation ...

Eve is a joyful, adventurous two-year-old "with a smile that lights up every room"Her parents describe her as a “bright ...

July 9, 2024 — A team of researchers has identified and located a population of stem-like cells ... New Research Platform Assesses Brain Cancer Mutations During Surgery May 30, 2024 — Brain ...

The British Citizen Youth Award, now in its ninth year, honoured 21 young people yesterday from across the UK that have made ...

Glioblastoma is the most common and aggressive type of primary brain tumor, with an average survival rate of 15 months, ...

Throughout his sports career, Pautsch remained a sports fan. He cited covering the NFL and NBA Drafts, going to the Super Bowl, and being a torch bearer for the 2002 Olympic Games in Salt Lake City as ...

A police officer who defied the odds to beat locked-in syndrome following a stroke is among the thousands of patients who ...